We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBK icon
1351
FB Financial Corp
FBK
$3.07B
$5.41M 0.01%
137,825
-5,635
-4% -$227K
CHX
1352
DELISTED
ChampionX
CHX
$5.4M 0.01%
272,150
+52,182
+24% +$1.18M
AMN icon
1353
AMN Healthcare
AMN
$1.28B
$5.4M 0.01%
49,216
+5,519
+13% +$546K
BCPC
1354
Balchem Corp
BCPC
$5.71B
$5.39M 0.01%
41,535
+2,046
+5% +$256K
SOFI icon
1355
SoFi Technologies
SOFI
$23.2B
$5.38M 0.01%
1,021,058
+86,759
+9% +$586K
OC icon
1356
Owens Corning
OC
$12.6B
$5.38M 0.01%
72,377
+15,783
+28% +$1.39M
EAGG icon
1357
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.97B
$5.37M 0.01%
109,720
+83,207
+314% +$4.12M
LDSF icon
1358
First Trust Low Duration Strategic Focus ETF
LDSF
$162M
$5.37M 0.01%
287,135
+222,160
+342% +$4.24M
EXP icon
1359
Eagle Materials
EXP
$6.57B
$5.36M 0.01%
48,775
-4,512
-8% -$555K
MGM icon
1360
MGM Resorts International
MGM
$11.1B
$5.36M 0.01%
185,113
-80,274
-30% -$2.88M
JLL icon
1361
Jones Lang LaSalle
JLL
$16.7B
$5.35M 0.01%
30,591
+1,255
+4% +$250K
PALC icon
1362
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$218M
$5.34M 0.01%
154,197
+13,718
+10% +$507K
BHVN
1363
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$5.34M 0.01%
36,629
-2,238
-6% -$286K
NRG icon
1364
NRG Energy
NRG
$25.2B
$5.32M 0.01%
139,424
+14,141
+11% +$578K
ESMT
1365
DELISTED
EngageSmart, Inc.
ESMT
$5.32M 0.01%
330,543
-20,239
-6% -$402K
FFA
1366
First Trust Enhanced Equity Income Fund
FFA
$473M
$5.31M 0.01%
325,201
-77,379
-19% -$1.4M
IFV icon
1367
First Trust Dorsey Wright International Focus 5 ETF
IFV
$234M
$5.31M 0.01%
300,453
+6,664
+2% +$130K
DKS icon
1368
Dick's Sporting Goods
DKS
$18.4B
$5.3M 0.01%
70,331
+1,741
+3% +$155K
KIM icon
1369
Kimco Realty
KIM
$16.1B
$5.29M 0.01%
267,852
+11,704
+5% +$269K
OUNZ icon
1370
VanEck Merk Gold Trust
OUNZ
$2.71B
$5.29M 0.01%
301,738
+14,288
+5% +$260K
WAT icon
1371
Waters Corp
WAT
$40.7B
$5.29M 0.01%
15,974
-1,876
-11% -$595K
IYJ icon
1372
iShares US Industrials ETF
IYJ
$1.95B
$5.28M 0.01%
59,894
-16,049
-21% -$1.54M
ACGL icon
1373
Arch Capital
ACGL
$33.5B
$5.27M 0.01%
115,883
+2,423
+2% +$112K
TXRH icon
1374
Texas Roadhouse
TXRH
$13.8B
$5.27M 0.01%
71,970
-10,482
-13% -$824K
ACWX icon
1375
iShares MSCI ACWI ex US ETF
ACWX
$11.9B
$5.26M 0.01%
116,971
-4,716
-4% -$228K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.